Last update: Feb. 1, 2017
Minimal risk for breastfeeding and infant.
It is a glycoside-sulphate derivative (sucrose) plus aluminum.
At latest update no published data on excretion into breastmilk were found.
Pharmacokinetic data (virtually non-absorbed with a high molecular weight) make it very unlikely the excretion into breastmilk in significant amounts, which in addition it would not be absorbed through the infant's intestine.
Medication with authorized use on infants.
We do not have alternatives for Sucralfate since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.